Physician profile
Colette Ho
NPI 1972521987
$1,655.45
in general payments reported to CMS, 2019-2025
23 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,482 · 2020: $23.27 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $284.32 | 2019 | |
| Janssen Biotech, INC. | $155.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $154.32 | 2019 | |
| Beone Medicines USA, INC. | $150.00 | 2025 | Tevimbra |
| Viiv Healthcare Company | $116.20 | 2019 | |
| Pfizer INC. | $77.80 | 2019 | |
| Lilly USA, LLC | $76.23 | 2019 | |
| Amgen INC. | $68.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.58 | 2019 | |
| Glaxosmithkline, LLC. | $60.81 | 2019 | |
| Bausch Health US, LLC | $57.76 | 2019-2020 | |
| Boston Scientific Corporation | $53.98 | 2019 | |
| Merck Sharp & Dohme LLC | $49.06 | 2019 | |
| Sanofi Pasteur INC. | $48.76 | 2019 | |
| Supernus Pharmaceuticals, INC. | $47.58 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $44.15 | 2019 | |
| Napo Pharmaceuticals INC | $42.54 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.97 | 2019 | |
| Seqirus USA INC | $19.81 | 2019 | |
| Allergan, INC. | $17.82 | 2019 | |
| Shire North American Group INC | $17.14 | 2019 | |
| Aytu Biopharma, INC. | $13.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colette Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.